19 March 2018 - - South San Francisco, California-based drug and medical device knowledge provider First Databank, Inc. (FDB) has released the FDB Opioid Risk Management Module that helps reduce the risk of opioid-related overdose and addiction potential, the company said.
This module provides a presentation of a daily Morphine Milligram Equivalents (MME) calculation to support regulatory compliance, along with an assessment of the potential additive respiratory and central nervous system depression side effects, all within the clinician's workflow.
Emerging pain management guidelines leverage MME as an attribute to describe the relative potency of medications that span different opiate ingredients.
The FDB Opioid Risk Management Module provides information that enables calculation of the relative potency of opioid-containing medications, and the identification of additive side effects known as the "double threat" and "triple threat," to improve safety and regulatory compliance in opioid use for patients.
FDB provides drug and medical device knowledge that helps healthcare professionals make precise decisions.
With thousands of customers worldwide, the company enables our information system developer partners to deliver valuable, useful, and differentiated solutions.